New York State Common Retirement Fund Collegium Pharmaceutical, Inc Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 10,076 shares of COLL stock, worth $292,808. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,076

Previous 13,276 24.1%

Holding current value

$292,808

Previous $427,000 8.9%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$31.4 - $39.07 $100,480 - $125,024	-3,200 Reduced 24.1%	10,076 $389,000
Q2 2024 Jul 31, 2024	SELL	$31.36 - $39.99 $4.49 Million - $5.72 Million	-143,040 Reduced 91.51%	13,276 $427,000
Q1 2024 May 07, 2024	SELL	$31.23 - $40.91 $1.4 Million - $1.83 Million	-44,796 Reduced 22.27%	156,316 $6.07 Million
Q4 2023 Feb 01, 2024	BUY	$21.16 - $30.8 $3.99 Million - $5.8 Million	188,347 Added 1475.5%	201,112 $6.19 Million
Q3 2023 Nov 07, 2023	BUY	$21.23 - $24.28 $2,250 - $2,573	106 Added 0.84%	12,765 $285,000
Q2 2023 Aug 07, 2023	SELL	$21.06 - $24.0 $93,253 - $106,272	-4,428 Reduced 25.91%	12,659 $272,000
Q1 2023 May 02, 2023	SELL	$23.0 - $29.88 $188,577 - $244,986	-8,199 Reduced 32.43%	17,087 $410,000
Q4 2022 Jan 30, 2023	SELL	$16.14 - $23.55 $498,564 - $727,459	-30,890 Reduced 54.99%	25,286 $587,000
Q3 2022 Nov 08, 2022	SELL	$15.46 - $20.1 $74,130 - $96,379	-4,795 Reduced 7.86%	56,176 $900,000
Q2 2022 Aug 04, 2022	BUY	$14.22 - $20.88 $86,443 - $126,929	6,079 Added 11.07%	60,971 $1.08 Million
Q1 2022 May 05, 2022	BUY	$17.2 - $22.5 $548,645 - $717,705	31,898 Added 138.72%	54,892 $1.12 Million
Q4 2021 Feb 02, 2022	SELL	$17.5 - $21.35 $85,242 - $103,995	-4,871 Reduced 17.48%	22,994 $430,000
Q3 2021 Nov 02, 2021	SELL	$17.75 - $25.39 $78,614 - $112,452	-4,429 Reduced 13.71%	27,865 $550,000
Q2 2021 Aug 02, 2021	BUY	$21.74 - $25.28 $6,391 - $7,432	294 Added 0.92%	32,294 $763,000
Q4 2019 Feb 05, 2020	SELL	$10.7 - $22.24 $32,099 - $66,720	-3,000 Reduced 8.57%	32,000 $659,000
Q2 2019 Aug 09, 2019	BUY	$10.62 - $16.59 $80,712 - $126,084	7,600 Added 27.74%	35,000 $460,000
Q4 2018 Feb 08, 2019	SELL	$14.78 - $19.68 $78,334 - $104,304	-5,300 Reduced 16.21%	27,400 $470,000
Q3 2018 Nov 07, 2018	SELL	$14.16 - $24.3 $214,283 - $367,731	-15,133 Reduced 31.64%	32,700 $482,000
Q2 2018 Aug 10, 2018	BUY	$21.79 - $28.29 $93,697 - $121,647	4,300 Added 9.88%	47,833 $1.14 Million
Q1 2018 May 10, 2018	BUY	$18.15 - $29.21 $76,230 - $122,682	4,200 Added 10.68%	43,533 $1.11 Million
Q4 2017 Feb 13, 2018	BUY	$9.3 - $19.14 $140,736 - $289,645	15,133 Added 62.53%	39,333 $726,000
Q2 2017 Aug 11, 2017	BUY	N/A	24,200	24,200 $303,000

Others Institutions Holding COLL

# of Institutions

255

Shares Held

36.9M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $992M
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Collegium Pharmaceutical, Inc Transaction History